Biomarkers Consortium

The Biomarkers Consortium brings together various partners to identify, develop and qualify potential biomarkers to improve drug development and regulatory decision-making. 

Spotlight

Spotlight
Minimal Residual Disease in Myeloma: Application for Clinical Care and New Drug Registration
Minimal Residual Disease in Myeloma: Application for Clinical Care and New Drug Registration
Spotlight
New Video–Vol-PACT: A Novel Cancer Imaging Project
https://www.youtube.com/watch?v=Rn6Fe5156C8
Spotlight
Mucosal Healing in Ulcerative Colitis
Mucosal Healing

Vision

Improving health through meaningful measurements.

Mission 

To create and lead cross-sector efforts that validate and qualify biomarkers and other drug development tools to accelerate better decision making for the development of new therapeutics and health technologies.